Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunnar Aus

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|November 12, 2009
Living with a prostate cancer diagnosis: a qualitative 2-year follow-upAnnikki Jonsson, Gunnar Aus, Carina Berterö
Scandinavian Journal of Urology and Nephrology|July 16, 2005
Prostate biopsy and anaesthesia: an overviewGunnar Aus, Jan-Erik Damber, Jonas Hugosson
European Journal of Cancer (Oxford, England : 1990)|July 24, 2007
Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised studySigrid Carlsson, Gunnar Aus, Catrin Wessman, et al.
Cancer|October 9, 2009
Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendeesAnna Grenabo Bergdahl, Gunnar Aus, Hans Lilja, et al.
Cancer|January 15, 2005
Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of SwedenGunnar Aus, David Robinson, Johan Rosell, et al.
European Urology|May 28, 2003
Prognostic factors and survival in node-positive (N1) prostate cancer-a prospective study based on data from a Swedish population-based cohortGunnar Aus, Kerstin Nordenskjöld, David Robinson, et al.
European Urology|August 29, 2006
Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer--results from a prospective, population-based randomized controlled trialGunnar Aus, Svante Bergdahl, Pär Lodding, et al.
BJU International|May 1, 2012
The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening TrialMaria Frånlund, Sigrid Carlsson, Johan Stranne, et al.
Cancer|March 26, 2004
Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinomaJonas Hugosson, Gunnar Aus, Hans Lilja, et al.
European Urology|January 22, 2004
Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratioGunnar Aus, Charlotte Becker, Stefan Franzén, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|November 12, 2009
Living with a prostate cancer diagnosis: a qualitative 2-year follow-upAnnikki Jonsson, Gunnar Aus, Carina Berterö
Scandinavian Journal of Urology and Nephrology|July 16, 2005
Prostate biopsy and anaesthesia: an overviewGunnar Aus, Jan-Erik Damber, Jonas Hugosson
European Journal of Cancer (Oxford, England : 1990)|July 24, 2007
Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised studySigrid Carlsson, Gunnar Aus, Catrin Wessman, et al.
Cancer|October 9, 2009
Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendeesAnna Grenabo Bergdahl, Gunnar Aus, Hans Lilja, et al.
Cancer|January 15, 2005
Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of SwedenGunnar Aus, David Robinson, Johan Rosell, et al.
European Urology|May 28, 2003
Prognostic factors and survival in node-positive (N1) prostate cancer-a prospective study based on data from a Swedish population-based cohortGunnar Aus, Kerstin Nordenskjöld, David Robinson, et al.
European Urology|August 29, 2006
Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer--results from a prospective, population-based randomized controlled trialGunnar Aus, Svante Bergdahl, Pär Lodding, et al.
BJU International|May 1, 2012
The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening TrialMaria Frånlund, Sigrid Carlsson, Johan Stranne, et al.
Cancer|March 26, 2004
Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinomaJonas Hugosson, Gunnar Aus, Hans Lilja, et al.
European Urology|January 22, 2004
Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratioGunnar Aus, Charlotte Becker, Stefan Franzén, et al.
Pageof 7